Related Experiment Video
Updated: Jul 12, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Reduced neuronal efficacy in progressive mild cognitive impairment: a prospective fMRI study on visuospatial
Patrizia Vannini1, Ove Almkvist, Thomas Dierks
1Department of Neurobiology, Care Sciences and Society, Division of Clinical Geriatrics, Karolinska Institutet, Karolinska University Hospital, Huddinge, 141 86 Stockholm, Sweden. Patrizia.Vannini@ki.se
Abstract:
Mild cognitive impairment (MCI) often refers to the preclinical stage of dementia, where the majority develop Alzheimer's disease (AD). Given that neurodegenerative burden and compensatory mechanisms might exist before accepted clinical symptoms of AD are noticeable, the current prospective study aimed to investigate the functioning of brain regions in the visuospatial networks responsible for preclinical symptoms in AD using event-related functional magnetic resonance imaging (fMRI). Eighteen MCI patients were evaluated and clinically followed for approximately 3 years. Five progressed to AD (PMCI) and eight remained stable (SMCI). Thirteen age-, gender- and education-matched controls also participated. An angle discrimination task with varying task demands was used. Brain activation patterns as well as task demand-dependent and -independent signal changes between the groups were investigated by using an extended general linear model including individual performance (reaction time [RT]) of each single trial. Similar behavioral (RT and accuracy) responses were observed between MCI patients and controls. A network of bilateral activations, e.g. dorsal pathway, which increased linearly with increasing task demand, was engaged in all subjects. Compared with SMCI patients and controls, PMCI patients showed a stronger relation between task demand and brain activity in left superior parietal lobules (SPL) as well as a general task demand-independent increased activation in left precuneus. Altered brain function can be detected at a group level in individuals that progress to AD before changes occur at the behavioral level. Increased parietal activation in PMCI could reflect a reduced neuronal efficacy due to accumulating AD pathology and might predict future clinical decline in patients with MCI.
Insights
Brain imaging in mild cognitive impairment (MCI) detected altered brain function in individuals who progressed to Alzheimer's disease (AD) before behavioral symptoms emerged. Increased parietal activation may predict future cognitive decline.
Area of Science:
- Neuroscience
- Cognitive Neurology
- Medical Imaging
Background:
- Mild cognitive impairment (MCI) is often a preclinical stage of Alzheimer's disease (AD).
- Neurodegenerative changes and compensatory mechanisms may precede overt clinical symptoms of AD.
- Identifying early biomarkers is crucial for timely intervention in AD progression.
Purpose of the Study:
- To investigate brain region functioning in visuospatial networks related to preclinical AD symptoms.
- To utilize event-related functional magnetic resonance imaging (fMRI) to detect alterations in MCI patients.
- To correlate brain activity with task demands and individual performance.
Main Methods:
- Prospective study of 18 MCI patients (5 progressing to AD [PMCI], 8 stable [SMCI]) and 13 controls.
- Event-related fMRI during an angle discrimination task with varying demands.
- Analysis using an extended general linear model incorporating reaction time (RT) for single trials.
Main Results:
- No significant behavioral differences (RT, accuracy) were found between MCI patients and controls.
- A bilateral activation network, including the dorsal pathway, increased linearly with task demand in all groups.
- PMCI patients exhibited a stronger task demand-brain activity relationship in the left superior parietal lobules (SPL) and increased task-independent activation in the left precuneus compared to SMCI and controls.
Conclusions:
- Altered brain function is detectable at a group level in individuals progressing to AD before behavioral changes are apparent.
- Increased parietal activation in PMCI may indicate reduced neuronal efficacy due to AD pathology.
- These findings suggest potential predictive value for future clinical decline in MCI patients.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
07:11Functional Magnetic Resonance Imaging (fMRI) of the Visual Cortex with Wide-View Retinotopic Stimulation
Published on: December 8, 2023